![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 6, 4192-4198, February 11, 2000
From the § Department of Biochemistry, University of
Alberta, Edmonton, Alberta T6G 2H7, Canada and the
¶ Department of Chemistry and Biochemistry, University of
Oklahoma, Norman, Oklahoma 73019
Site-directed mutagenesis was used to investigate
the mechanism of interaction between the catalytic subunit of human
protein phosphatase-1 (PP-1c
Inhibition of Protein Phosphatase-1 by Clavosines A and B
NOVEL MEMBERS OF THE CALYCULIN FAMILY OF TOXINS*
§,
) and members of the calyculin family of toxins. Clavosines A and B are related to calyculins but are
glycosylated with a trimethoxy rhamnose group. We provide experimental
evidence implicating Tyr-134 as an important residue in PP-1c
that
mediates interactions with the calyculins. Mutation of Tyr-134 to Phe, to prevent hydrogen bond formation, resulted in a slight increase in
sensitivity of PP-1c
to clavosines A and B and calyculin A. In
contrast, a Y134A mutant was 10-fold less sensitive to inhibition by
all three inhibitors. The greatest effect on inhibition was found by
substituting an Asp for Tyr-134 in the phosphatase. Clavosine B
inhibited PP-1c
Y134D with a 310-fold decrease in potency. Clavosine
A and calyculin A were also markedly poorer inhibitors of this mutant.
These results suggest that a hydrogen bond between Tyr-134 and the
calyculins is unlikely to be essential for inhibitor binding to the
phosphatase. The clavosines and calyculin A were tested for their
ability to inhibit other mutants of PP-1c
(including Ile-133,
Val-223, and Cys-291). Our mutagenesis studies provide an experimental
basis for assessing models of calyculin binding found in the literature
(Lindvall, M. K., Pihko, P. M., and Koskinen, A. M. (1997) J. Biol. Chem. 272, 23312-23316; Gupta, V.,
Ogawa, A. K., Du, X., Houk, K. N., and Armstrong, R. W. (1997) J. Med. Chem. 40, 3199-3206; Gauss, C. M., Sheppeck, I. J., Nairn, A. C., and Chamberlain, R. (1997)
Bioorg. Med. Chem. 5, 1751-1773). A new model for
clavosine and calyculin A binding to PP-1c is presented that is
consistent with previous structure-function experiments and which
accommodates key structural features of the clavosines, including the
novel rhamnose moiety.
*
This work was supported by Grant GR-13303 from the Medical
Research Council of Canada (to C. F. B. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of a Ph.D. Studentship and Dissertation Fellowship from
the Alberta Heritage Foundation for Medical Research and the University
of Alberta. To whom correspondence should be addressed. Tel.: (780)
492-3167; Fax: (780) 492-0095; Email: tara_mccready@ darwin.biochem.ualberta.ca.
This article has been cited by other articles:
![]() |
J. T. Maynes, K. R. Perreault, M. M. Cherney, H. A. Luu, M. N. G. James, and C. F. B. Holmes Crystal Structure and Mutagenesis of a Protein Phosphatase-1:Calcineurin Hybrid Elucidate the Role of the {beta}12-{beta}13 Loop in Inhibitor Binding J. Biol. Chem., October 8, 2004; 279(41): 43198 - 43206. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. J. Law, J. C. Everitt, M. D. Beatch, C. F. B. Holmes, and T. C. Hobman Phosphorylation of Rubella Virus Capsid Regulates Its RNA Binding Activity and Virus Replication J. Virol., February 1, 2003; 77(3): 1764 - 1771. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |